Perrigo revises segment reporting; FY2025 includes $1.36B impairment charge

PERRIGO Co plc

Self Care segment net sales $2,533.5M in FY2025, down from $2,554.3M in FY2024.
Infant Formula segment net sales $359.0M in FY2025, down from $397.0M in FY2024.
Adjusted operating income for segments totaled $682.6M in FY2025, consolidated adjusted operating income $622.3M.
Q4 2025 goodwill impairment of $1.3B plus $33.6M equity method impairment contributed to reported operating loss of $1,122.2M.
Segment change effective Q1 2026; recast historical data provided for comparability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.